___
Breast Cancer: Positive in mother at age ___ and maternal 
grandmother at ___.
___ Cancer: Denied.
 
Physical Exam:
Per PRS Post Op Check note on ___:
.
Gen: [x] NAD, [x] AAOx3
CV: [x] RRR, [] murmur
Resp: [x] breaths unlabored, [x] CTAB, [] wheezing, [] rales
Abdomen: soft, non distended, appropriately tender, w/o 
rebound/guarding
Wounds: -Left breast: incisions clean, dry, intact, flap looks 
viable, vioptix on 46% signal quality 88. Left axillary drain 
insertion points looks c/d/I, drains(x2) are in place, holding 
suction.
        -Right breast: incisions clean, dry, intact, flap looks 
viable, vioptix on 66% signal quality 99. Right axillary drain 
insertion points looks c/d/I, drains(x2) are in place, holding 
suction.
        -Abdomen: Incision looks clean, dry, and intact, both 
drains holding suction, no sing of infection. 
Ext: [x] warm, [] tender, [] edema
Foley: [x] Yes    [] No
.
VITALS:
___: Weight: 246 (Patient Reported)
BP: 110/70 HR: 99 RR: 14 SaO2 95%
 
Pertinent Results:
___ 05:19AM BLOOD WBC-12.1* RBC-3.35* Hgb-9.6* Hct-29.4* 
MCV-88 MCH-28.7 MCHC-32.7 RDW-14.0 RDWSD-45.1 Plt ___
 
Brief Hospital Course:
The patient was admitted to the plastic surgery service on 
___ and had a bilateral skin sparing mastectomy, 
immediate right SIEA flap, and left ___ flap.  The patient 
tolerated the procedure well. 
.
Neuro: Post-operatively, the patient received Morphine PCA with 
good effect and adequate pain control. When tolerating oral 
intake, the patient was transitioned to oral pain medications. 
.
CV: The patient was stable from a cardiovascular standpoint; 
vital signs were routinely monitored.
.
Pulmonary: The patient was stable from a pulmonary standpoint; 
vital signs were routinely monitored.
.
GI/GU: Post-operatively, the patient was given IV fluids until 
tolerating oral intake. Her diet was advanced when appropriate, 
which was tolerated well. She was also started on a bowel 
regimen to encourage bowel movement. Foley was removed on POD#2. 
Intake and output were closely monitored. 
.
ID: Post-operatively, the patient was started on IV cefazolin, 
then switched to PO cefadroxil for discharge home. The patient's 
temperature was closely watched for signs of infection. 
.
Prophylaxis: The patient received subcutaneous heparin during 
this stay, and was encouraged to get up and ambulate as early as 
possible.
.
At the time of discharge on POD#4, the patient was doing well, 
afebrile with stable vital signs, tolerating a regular diet, 
ambulating, voiding without assistance, and pain was well 
controlled.
 
Medications on Admission:
1. Albuterol x1 puff inh prn asthma
2. Hydrochlorothiazide 25 mg tablet
3. Lorazepam 0.5 mg tablet PRN
4. Meloxicam 7.5 mg tablet 
 
Discharge Medications:
1.  Acetaminophen 650 mg PO Q6H pain, HA, T>100 degrees  
2.  Aspirin 121.5 mg PO DAILY after first PR dose in PACU. 
(121.5 mg = one and one half baby aspirin) 
RX *aspirin 81 mg 1.5 tablet(s) by mouth once a day Disp #*45 
Tablet Refills:*0 
3.  cefaDROXiL 500 mg oral Other BID Duration: 1 Week 
RX *cefadroxil 500 mg 1 capsule(s) by mouth twice a day Disp 
#*14 Capsule Refills:*0 
4.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*14 Capsule Refills:*0 
5.  HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate 
RX *hydromorphone 2 mg 1 tablet(s) by mouth every six (6) hours 
Disp #*24 Tablet Refills:*0 
6.  Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN wheezing  
 
Discharge Disposition:
Home With Service
 
Facility:
___
 
Discharge Diagnosis:
BRCA2 mutation